Kato Jonas Njunwa

Kato Jonas Njunwa

Auto-generated profile, based on publicly available information

Kato Jonas Njunwa

School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Studies on Ethno-Medicine
Verified
Journal Article
Closed access
GMGodfrey M. Mubyazi
Godfrey M. Mubyazi
AMAdiel K. Mushi
Adiel K. Mushi
ESElizabeth Shayo
Elizabeth Shayo
KMKassembe Mdira
Kassembe Mdira
JIJoyce Ikingura
Joyce Ikingura
KNKato J. Njunwa
Kato J. Njunwa
A study was conducted to explore the views of villagers on the existence and functioning of local primary health-care (PHC) committees, village health workers (VHWs), skilled staff at government health facilities and their responsiveness to community health needs in Mkuranga district, Tanzania. Information was collected through separate group discussions with some members of households, local PHC committees and district health managers and semistructured interviews with individual household members, clinical and nursing staff at peripheral government facilities, and indepth interviews with officers in central and local government departments at district level. Some villagers did not recognise the existence of VHWs and PHC committees at community level. There was a common report from the village respondents that some nurses behaved impolitely to antenatal clients. Dissatisfaction with diagnostic and prescription skills of rural medical-aides and laboratory services was reported by the majority of the residents, albeit some health staff were not happy with villagers complaining while knowing the constrained health staff working conditions.To ensure a sense of public trust, ownership and use of the existing health service system, community members need regular and timely feedback on health service delivery constraints and the existing community based health organisations for them to effectively participate in health development matters.

15 June 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
GGGaetan Gatete
Gaetan Gatete
KNKato J Njunwa
Kato J Njunwa
PMPatrick Migambi
Patrick Migambi
JNJoseph Ntaganira
Joseph Ntaganira
ANAlbert Ndagijimana
Albert Ndagijimana
Non-conversion of sputum smear prolongs the infectivity of pulmonary tuberculosis patients and has been associated with unfavorable tuberculosis (TB) treatment outcomes. Nevertheless, there is a limited evidence on predictors of sputum smear non-conversion among smear-positive PTB (SPPTB) patients in Rwanda. Therefore, this study aimed to determine the factors associated with sputum smear non-conversion after two months of treatment among SPPTB patients in Rwanda. A cross-sectional study was conducted among SPPTB patients registered in the national electronic TB reporting system by all health facilities countrywide (Rwanda) from July 2019 to June 2021. Eligible patients who had completed the first two months of anti-TB treatment and with smear results at the end of the second month of treatment were included in the study. Bivariate and multivariate logistic regression analyses were done using STATA version 16 to determine the factors associated with sputum smear non-conversion. Adjusted odds ratio (OR), 95% confidence interval (CI), and p-value < 0.05 was considered statistically significant. This study included 7,211 patients. Of them, 632 (9%) patients had sputum smear non-conversion at the end of the second month of treatment. In multivariate logistic regression analysis, age groups of 20–39 years (AOR = 1.7, 95% CI: 1.0-2.8) and 40–59 years (AOR:2, 95% CI: 1.1–3.3), history of first-line TB treatment failure (AOR = 2, 95% CI: 1.1–3.6), follow-up by community health workers(CHWs) (AOR = 1.2, 95% CI: 1.0-1.5), BMI < 18.5 at TB treatment initiation (AOR = 1.5, 95% CI: 1.2–1.8), and living in Northern Province of Rwanda (AOR = 1.4, 95% CI: 1.0–2.0), were found to be significantly associated with sputum smear non-conversion after two months of treatment. Sputum smear non-conversion among SPPTB patients remains low in Rwanda compared to countries of similar health care setting. Identified risk factors for sputum smear non-conversion among SPPTB patients in Rwanda were age (20–39 years, 40–59 years), history of first-line TB treatment failure, follow up by CHWs, BMI < 18.5 at TB treatment initiation and residence (Northern province).

31 December 2023 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
PDF file
DPDaniel Pyuza
Daniel Pyuza
SMShiferaw Mitiku
Shiferaw Mitiku
OSOmary Swalehe
Omary Swalehe
VKVedaste Kagisha
Vedaste Kagisha
KNKato Jonas Njunwa
Kato Jonas Njunwa
Availability of the health commodities in public health facilities in Tanzania remains a challenge, and has been reported to be below 70%. Moreover, Medical Stores Department’s capacity to supply health commodities has been only 40%. Therefore, Jazia Prime Vendor System (Jazia PVS) was outsourced to complement the Medical Stores Department. In 2017 Jazia PVS was introduced in Singida Region after being piloted in three other Regions. This study therefore, was conducted to assess the performance of Jazia PVS in enhancing the availability of the health commodities in the public health facilities between 2017 and 2019 in Singida Region, Tanzania. A mixed method pre- and post-evaluation analytical study design was used in all the selected public health facilities in the Municipal and District Councils of Singida Region, Tanzania. These included 138 public health facilities: One Regional Referral Hospital, four District Hospitals, 19 Health Centres and 114 Dispensaries. Percent availability of health commodities was abstracted from electronic logistics management information system. Documentary review involved quarterly orders, Jazia PVS delivery notes, and payment vouchers; while all the 138 pharmacists incharge were interviewed. The mean availability of health commodities was modestly higher after adoption of Jazia PVS (mean = 59.17%, SD = 6.12%) than before Jazia PVS (mean = 54.39%, SD = 5.36%); and the difference between means was 4.78% (t = -9.49, df = 136, p < 0.001). Furthermore, 20.3% (109/421) of orders were fulfilled, while 58% (312/421) were not, (χ2 = 10.46, df = 6, p = 0.1067). About 73.7% of orders (320/434) were delivered on time, while 26.3% (114/434) delayed, (χ2 = 121, df = 6, p < 0,001). Prompt payment to Jazia PVS was 43.0% (164/381) deliveries, while 57.0% (217/382) were not punctual, (χ2 = 26, df = 6, p < 0.001). Satisfaction level of the pharmacists incharge for Jazia PVS was 11.8%, (χ2 = 78.04, df = 3, p < 0.001). With Jazia PVS, availability of health commodities improved by 4.78% in 2 years. Prompt payment of Jazia PVS will enhance performance of the vendor.

14 January 2025 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ATAnitha Tuyishime
Anitha Tuyishime
IHInnocent Hahirwa
Innocent Hahirwa
KNKato Jonas Njunwa
Kato Jonas Njunwa
JNJohn Nyiligira
John Nyiligira
Strong partnerships, community engagement, and multisectoral collaboration in the health supply chain are synergistic pillars towards achieving universal health coverage. In Rwanda, the health supply chain involves the collaboration of various stakeholders, including distributors, manufacturers, wholesalers, and customers. However, since the eruption and ending of COVID-19, there has not been any study to assess stakeholders' perspectives on the status of the benefits, challenges, and best practices of collaborative partnerships among health supply chain stakeholders in Rwanda. Therefore, this research was conducted to fill that gap in order to devise ways for improved visibility, coordination, and efficiency of the health supply chain management system in Rwanda. This quantitative cross-sectional study, collected data from 11th April to 18th May 2024. It involved 103 respondents from 54 institutions engaged in the management of the health commodities supply chain in Rwanda. These were the Ministry of Health, Rwanda Biomedical Center, Rwanda Food and Drugs Authority, Rwanda Medical Supply Ltd, other Central Medical Stores namely Bureau des Formations Médicales Agréées du Rwanda (BUFMAR) and Medical and Allied Service Solutions (MEDIASOL); private wholesale pharmacies, non-government organizations, and Health Facilities (hospitals). A sample size of 103 respondents was determined by the Yamane formula, and purposive sampling was used to select the respondents to complete a self-administered questionnaire specifically developed for this study. The outcome measures were perceived benefits, challenges, and strategies to overcome challenges of collaborative partnerships among health supply chain stakeholders in Rwanda. Availability of health commodities ranked at 98.0%, infrastructure/accessibility of health services (86.4%), and cost-effectiveness (84.5%) were the most mentioned benefits. Most stated challenges included insufficient financial resources from stakeholders (84.5%), shortage of skilled staff (77.7%), and limited dialogue or lack of information sharing (69.9%). Most respondents agreed that collaborative partnerships can be improved by political will (96.1%), supply performance measurement (92.2%), improved financing policies (84.5%), fostering trust and transparency building (78.6%), and a well-structured health supply chain (72.5%). Establishing and strengthening stakeholder collaborations are essential for improved performance. Staff capacity strengthening and mutual information sharing will reduce risks, and improve forecasting, leading to cost-effectiveness and customer satisfaction.

14 October 2022 in Research Square
Verified
Preprint
Open access
PDF file
AMAriane Mutabaruka
Ariane Mutabaruka
JSJurdas Sezirahiga
Jurdas Sezirahiga
ENEric Nyirimigabo
Eric Nyirimigabo
IHInnocent Hahirwa
Innocent Hahirwa
KNKato Jonas Njunwa
Kato Jonas Njunwa
Background A strong health system cannot function without a well-designed, well-operated, and well-maintained supply chain management system. Temperature-sensitive products within the supply chain are products that encompass pharmaceutical goods or products, which, when not stored or transported within predefined environmental conditions and/or within predefined time limits, are degraded and rendered not fully effective. The objective of this study was to evaluate the compliance to the good distribution practices of temperature-sensitive products in Rwanda. Methods A cross-sectional study was conducted at a medical supply company in Rwanda and involved 30 staff members managing temperature-sensitive products. The staff came from the Quality Assurance and quality control unit, Warehouse and logistics unit, Sales and marketing unit, Distribution unit, as well as some branch directors. Interviews were conducted and historical data on recorded temperature and humidity levels in storerooms and refrigerators/freezers as well as transit temperature data from representative district branches were collected for a period of three years (2017–2019). All data were analyzed using SPSS version 25. For compliance, temperature and relative humidity were compared with international standards. Results It was found that the Standard Operating Procedures were available but not updated to ensure compliance. The scarcity of trained staff was found to be the main factor hindering adherence to standards, hence monitoring of temperature and relative humidity sometimes had loopholes that need to be addressed. This study also discovered that adherence to recommended temperature ranges for the products was compromised by inconsistency in recording and reporting temperature and humidity, and a lack of temperature monitoring tools and qualified equipment. Conclusions The study revealed the weaknesses that exist in the process of distribution of temperature-sensitive products at the medical supply company, which mainly, are attributed to paucity of trained staff. Strategic planning for short, medium, and long-term remedies will require that all parties involved in the management of these products work together towards upholding the standard.